Atlas Genomics is a Seattle-based CRO dedicated to providing world-class research services while maintaining a close, personal relationship with our clients and partners. We offer unique, custom assays tailored to specific scientific needs — in addition to standard, off-the-shelf solutions — and we pride ourselves in returning results quickly.
Learn more about our CRO services.
Thermo Fisher Scientific interviewed Lisa Butterfield, who runs the immune monitoring and biomarkers labs at UPCI/UPMC and is the current president of the Society for the Immunotherapy of Cancer (SITC). This interview highlights the utility of the Thermo Fisher ProcartaPlex Immuno-Oncology Checkpoint Panel and ProcartaPlex Immune Monitoring 65 Plex panel for biomarker discovery using samples from clinical trials.
Read the Thermo Fisher Scientific interview.
The ProcartaPlex Immuno-Oncology Checkpoint Panel is the first commercially available multiplex immunoassay system that allows simultaneous detection of the soluble forms of the following analytes: BTLA, GITR, HVEM, IDO, LAG-3, PD-1, PD-L1, PD-L2, Tim-3, CD28, CD80, 4-1BB, CD27, and CTLA-4. Soluble isoforms, or shed variants of these molecules, have been described and can be quantitated by this innovative assay.
ProcartaPlex™ immunoassays are the ideal solution for assessing multiple protein biomarkers in a single sample. ProcartaPlex assays use Luminex™ xMAP technology for the multi-analyte detection of secreted proteins including cytokines, chemokines, growth factors and other proteins.
We look forward to working with you to formulate a plan that addresses your specific research needs and goals, no matter the scope or the size. We are determined to fulfill your unique CRO requests.
Get in touch with one of our representatives.